|
Hi Birgitta - thanks for posting that article. Good that they find such markers.
I always wonder why for high risk patients they go straight to Vidaza, and when that fails, they don't try revlimid or Thalomide.. I do see studies with chromosome 5 anomalies and I see combination therapy like Aza or Decibide with revlimid but I never saw any study about hi risk MDS and either revlimid or Thalomide alone.
Regards, Steve
|